Lilly Stock Jumps After Phase 3 Weight-Drug Readout
Lilly stock jumps after Phase 3 readout for a next-generation weight-loss drug exceeded expectations. Investors see d...
Explore the core reasons index funds tend to outperform active funds over the long run, focusing on fee drag, turnover impact, and diversification.
22,990 articlesLilly stock jumps after Phase 3 readout for a next-generation weight-loss drug exceeded expectations. Investors see d...
As AI excitement cools, investors parse the shift from trade short-term bets to a lasting investment decade. BlackRoc...
Two consumer-facing stocks sit at a crossroads: GameStop is tightening its turnaround with a leaner footprint, while ...
Joby Aviation shares hover near $9 as certification hurdles and a new funding round set the stage for a possible upsi...
A veteran Bernie strategist warns Democrats are repeating past mistakes with Democratic Socialists. Mamdani’s decisiv...
Intel's turnaround gains traction amid AI-driven demand and a narrowing foundry loss gap, fueling a debate about whet...
Abbott Laboratories and Pfizer both delivered solid Q1 2026 numbers, yet the market sentiment diverged. Abbott slumpe...
AT&T tells CNBC that Starlink faces a late-arrival risk, citing a fiber-first moat and evolving wireless growth. The ...
The schwab u.s. dividend equity ETF surged into 2026, led by high-quality dividend growers and favorable market condi...
If you have $1,000? these stocks could form the core of a solid, long‑term portfolio. Learn why two consumer staples ...
A well-planned $1,000 investment can grow into a durable portfolio. Learn a practical framework, three focused stock ...
A niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...